The job expects the MDX narrative as the returned artifact (extracted from the final text output). I have all source material from the context pack. Producing the executive summary now.
Global Wound Care Medical Group, a Professional Corporation — a Medicare-dependent mobile wound care provider that derived roughly 90% of its revenue from government healthcare programs — is in Chapter 11 wind-down in the Southern District of Texas (Houston) before Judge Christopher M. Lopez after ceasing all operations on December 12, 2025. The case was precipitated by the Centers for Medicare & Medicaid Services' September 11, 2024 suspension of Medicare payments through its contractor Qlarant, triggered by "credible allegations of fraud" tied to five 2023 claims totaling approximately $11,150.65 but freezing an estimated $208 million in prepetition receivables and collapsing the debtor's primary revenue stream. The company filed its voluntary Chapter 11 petitionDkt. 1 on October 21, 2024, supported by the First Day Declaration of CFO Ralph CetruloDkt. 8, which disclosed total assets of roughly $187 million against liabilities of $157 million and described operations across 20+ states treating more than 2,000 wounds daily.
Postpetition liquidity was the case's central organizing problem. The court authorized an early senior secured superpriority DIP facility, memorialized through the order approving the Third Amendment to the DIP Credit AgreementDkt. 457, which sustained operations through 2024 and into 2025. As Medicare Additional Documentation Requests intensified and collections deteriorated, the debtor returned in October 2025 with an seeking up to $10.7 million from East West Bank — a priming, superpriority term loan at 12.0% with a 120-day maturity, guaranteed by affiliate Wound Pros Management Group, Inc. — to preserve operations and nearly 900 jobs. That interim facility was repaid shortly after entry of the final financing order, and the debtor wound down operations within weeks.
The restructuring has run alongside active government enforcement and litigation. The U.S. Department of Justice responded to the First Day DeclarationDkt. 17 within days of the filing, and CMS/DOJ negotiations over the suspended receivables, suspense-account funds, and a potential settlement have consumed the bulk of professional effort through 2026. The debtor also opened an adversary proceeding against Wells Fargo Bank, N.A. by complaintDkt. 1 in April 2025. The claims register remains sparse — one secured claim of $10.7 million and one general unsecured claim of roughly $155.6 million — consistent with a case whose central economic dispute, the suspended Medicare receivables, has not yet been reduced to an allowed claim.
The matter is now a structured wind-down rather than a going-concern reorganization. With operations halted, recent docket activity is almost entirely administrative: the debtor is disposing of patient records under 11 U.S.C. § 351, with publication noticeDkt. 427 completed in April 2026 triggering a 365-day waiting period before destruction, while professional fee statements — most recently the seventeenth monthly statement of Dentons US LLPDkt. 428 — show fees falling from roughly $184,000 in November 2025 to roughly $41,000 in March 2026, with remaining hours concentrated on CMS/DOJ settlement strategy and wind-down budgeting. No plan has been filed or confirmed; the near-term value drivers are the outcome of the CMS/DOJ settlement and any recovery on the suspended Medicare suspense-account funds.
Final status: complete. Wrote the executive_summary MDX narrative (4 paragraphs, ~470 words) for case_watch_id 2097, citing only allowed_citations (Dkt. 1, 8, 17, 457, 311, 427, 428, and the Wells Fargo adversary Dkt. 1), leading with current wind-down posture.
